Osteoclast morphology in autosomal recessive malignant osteopetrosis due to a TCIRG1 gene mutation

Elisabeth Bruder1, Thomas Stallmach, Karin Peier

  • 1Pediatric Pathology Section, Department of Pathology, University Hospital Zurich, Switzerland.

Insights

Bone marrow transplantation successfully treated a TCIRG1 gene mutation causing autosomal recessive osteopetrosis. Donor osteoclasts were observed, indicating active bone resorption before radiological changes.

Area of Science:

  • Genetics
  • Hematology
  • Orthopedics

Background:

  • Osteopetrosis is a rare genetic disorder characterized by defective osteoclast function, leading to impaired bone resorption and increased bone density.
  • Malignant autosomal recessive osteopetrosis, often caused by mutations in the TCIRG1 gene (encoding the vacuolar H+-ATPase a3 subunit), presents in infancy with severe skeletal abnormalities and potential complications.
  • Hematopoietic stem cell transplantation (HSCT) is a potential curative treatment for osteopetrosis, aiming to replace the defective osteoclast precursors with functional donor cells.

Observation:

  • A 3-month-old infant with TCIRG1-associated autosomal recessive osteopetrosis underwent HLA-compatible bone marrow transplantation.
  • Pre-transplant bone biopsies revealed immature bone trabeculae, absent medullary hematopoiesis, and functionally deficient osteoclasts lacking ruffled borders.
  • Post-transplant biopsies demonstrated the presence of donor-derived osteoclasts exhibiting characteristic ruffled borders and intracytoplasmic mineral crystals, indicative of active bone resorption.

Findings:

  • Successful engraftment of donor hematopoietic stem cells led to the development of functional osteoclasts.
  • Morphological evidence of active bone resorption by donor osteoclasts was observed on biopsy.
  • These findings suggest that HSCT can restore osteoclast function in TCIRG1-deficient osteopetrosis, even before radiological signs of bone remodeling are apparent.

Implications:

  • Bone marrow transplantation is a viable therapeutic strategy for malignant autosomal recessive osteopetrosis due to TCIRG1 mutations.
  • Morphological analysis of bone biopsies can serve as an early indicator of successful osteoclast engraftment and functional recovery post-transplantation.
  • Genetic diagnosis and early intervention, such as HSCT, are crucial for improving outcomes in patients with osteopetrosis.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...